Skip to main content

US ClosedU.S. Closed

KALA: KALA BIO, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions.

52W Range

0thpctl

Volume

20.54×avg

Market Cap

13.35MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

KALA BIO, Inc.

KALANASDAQ Global Select·USD·Closed

KALA BIO, Inc.

KALANASDAQ·USD·Closed

$0.69

−15.02%

$0.69

−$0.12 (15.02%)

52W Range

0thpctl

Volume

20.54×avg

Mkt Cap

13.35MUSD

P/E

-0.0TTM

Div Yield

–ann